跳至主要内容
临床试验/RBR-7tqc7k
RBR-7tqc7k已完成未知

Tamoxifen population pharmacokinetics in breast cancer patients: metabolism study, genetic polymorphism, hormonal status and age

Faculdade de Ciências Farmacêuticas de Ribeirão Preto0 个研究点开始时间: 2018年7月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18Y 至 90Y(—)
性别
Female

入选标准

  • Breast cancer patients on adjuvant tamoxifen treatment for more than 80 days who have not been treated with other co-medications that may interfere with the study have been investigated. For the study, two groups of patients will be delimited according to age and hormonal status, being a premenopausal group (age less than 50 years) and another postmenopause (age higher than 60 years).

排除标准

  • Patients with comorbidities that interfere with the metabolism of tamoxifen and the probe drugs were excluded; patients who have previously chemotherapy and / or target therapy; patients who have contraindications to the use of the probe drugs metoprolol, midazolam and fexofenadine; and psychiatric patients unable to understand ICF.

研究者

发起方
Faculdade de Ciências Farmacêuticas de Ribeirão Preto

相似试验